Moderna, Inc.‘s (NASDAQ: MRNA) UK chief Darius Hughes defended Britain’s drug pricing policies after the country was branded the “worst in Europe.”
Moderna Stands By UK As Pharma Giants Criticize Pricing, UK Secures First Onshore mRNA Vaccine Production Centre
